Total Payments
$2,209
2022 Payments
$20.08
Companies
12
Transactions
44
Medicare Patients
17,895
Medicare Billing
$4.2M
Payment Breakdown by Category
Travel$1,116 (50.5%)
Other$540.00 (24.5%)
Food & Beverage$511.10 (23.1%)
Education$41.88 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,116 | 3 | 50.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $540.00 | 14 | 24.5% |
| Food and Beverage | $511.10 | 24 | 23.1% |
| Education | $41.88 | 3 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $1,116 | 3 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $540.00 | 14 | $0 (2017) |
| Janssen Biotech, Inc. | $197.97 | 11 | $0 (2020) |
| Gilead Sciences Inc | $103.45 | 1 | $0 (2017) |
| PFIZER INC. | $71.03 | 5 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $39.77 | 3 | $0 (2018) |
| Amgen Inc. | $35.55 | 2 | $0 (2022) |
| Celgene Corporation | $27.51 | 1 | $0 (2017) |
| Horizon Pharma plc | $22.36 | 1 | $0 (2017) |
| AbbVie, Inc. | $18.85 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $20.08 | 1 | Amgen Inc. ($20.08) |
| 2020 | $24.57 | 1 | Janssen Biotech, Inc. ($24.57) |
| 2019 | $1,261 | 12 | Intuitive Surgical, Inc. ($1,116) |
| 2018 | $71.47 | 4 | Janssen Biotech, Inc. ($27.66) |
| 2017 | $831.12 | 26 | SANOFI-AVENTIS U.S. LLC ($540.00) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/13/2022 | Amgen Inc. | Tavneos (Drug) | Education | In-kind items and services | $20.08 | General |
| Category: Not Applicable | ||||||
| 03/02/2020 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Immunology | ||||||
| 12/11/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $309.51 | General |
| Category: SURGERY | ||||||
| 12/09/2019 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Immunology | ||||||
| 12/05/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $787.04 | General |
| Category: SURGERY | ||||||
| 12/05/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $19.00 | General |
| Category: SURGERY | ||||||
| 08/19/2019 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Immunology | ||||||
| 07/08/2019 | Janssen Biotech, Inc. | SIMPONI (Biological) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: Immunology | ||||||
| 07/02/2019 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: Immunology | ||||||
| 06/10/2019 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Immunology | ||||||
| 05/09/2019 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Immunology | ||||||
| 05/01/2019 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Immunology | ||||||
| 04/04/2019 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Immunology | ||||||
| 03/01/2019 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA | Food and Beverage | In-kind items and services | $2.37 | General |
| Category: Immunology | ||||||
| 07/03/2018 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: IMMUNOLOGY | ||||||
| 05/08/2018 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), STELARA | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Immunology | ||||||
| 04/25/2018 | Actelion Pharmaceuticals US, Inc. | OPSUMIT MACITENTAN (Drug) | Education | In-kind items and services | $10.90 | General |
| Category: CARDIOVASCULAR DISORDERS | ||||||
| 01/30/2018 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: INFLAMMATION | ||||||
| 12/06/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
| 12/01/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
| 11/01/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
| 10/27/2017 | Actelion Pharmaceuticals US, Inc. | OPSUMIT MACITENTAN (Drug) | Education | In-kind items and services | $10.90 | General |
| Category: CARDIOVASCULAR DISORDERS | ||||||
| 10/10/2017 | Amgen Inc. | Enbrel (Biological), Prolia | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Inflammation | ||||||
| 10/04/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
| 09/06/2017 | SANOFI-AVENTIS U.S. LLC | SYNVISC-ONE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: OSTEOARTHRITIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 53 | 5,700 | 101,288 | $5.2M | $1.4M |
| 2022 | 55 | 4,280 | 72,827 | $3.5M | $939,360 |
| 2021 | 48 | 4,202 | 84,199 | $5.7M | $1.1M |
| 2020 | 44 | 3,713 | 42,803 | $3.5M | $691,561 |
Total Patients
17,895
Total Services
301,117
Medicare Billing
$4.2M
Procedure Codes
200
All Medicare Procedures & Services
200 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 318 | 26,220 | $1.6M | $480,378 | 30.0% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 15 | 40,950 | $778,050 | $191,692 | 24.6% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 15 | 5,200 | $556,400 | $168,784 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 664 | 1,303 | $394,809 | $139,661 | 35.4% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 28 | 17,640 | $546,840 | $139,350 | 25.5% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 12 | 2,060 | $208,060 | $53,949 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 266 | 266 | $157,206 | $36,840 | 23.4% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 321 | 467 | $176,993 | $33,040 | 18.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 55 | 241 | $207,019 | $30,652 | 14.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 294 | 353 | $73,424 | $26,367 | 35.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 231 | 231 | $69,993 | $10,615 | 15.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 70 | 129 | $35,316 | $8,293 | 23.5% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 103 | 197 | $21,780 | $6,824 | 31.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 413 | 633 | $25,953 | $6,531 | 25.2% |
| 82306 | Vitamin d-3 level | Office | 2023 | 210 | 220 | $21,120 | $6,382 | 30.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 498 | 706 | $7,766 | $5,930 | 76.4% |
| 86235 | Measurement of antibody for assessment of autoimmune disorder, any method | Office | 2023 | 49 | 327 | $19,293 | $5,623 | 29.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 82 | 96 | $42,720 | $5,526 | 12.9% |
| 73110 | X-ray of wrist, minimum of 3 views | Office | 2023 | 63 | 124 | $15,252 | $4,880 | 32.0% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 64 | 122 | $11,193 | $4,092 | 36.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 219 | 386 | $11,966 | $2,931 | 24.5% |
| 97530 | Therapy procedure using functional activities | Office | 2023 | 25 | 96 | $9,888 | $2,835 | 28.7% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 44 | 70 | $8,540 | $2,732 | 32.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 199 | $25,472 | $2,613 | 10.3% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 82 | 410 | $10,660 | $2,519 | 23.6% |
About Dr. David Wolfe, MD
Dr. David Wolfe, MD is a Rheumatology healthcare provider based in Chevy Chase, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104825249.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Wolfe, MD has received a total of $2,209 in payments from pharmaceutical and medical device companies, with $20.08 received in 2022. These payments were reported across 44 transactions from 12 companies. The most common payment nature is "Travel and Lodging" ($1,116).
As a Medicare-enrolled provider, Wolfe has provided services to 17,895 Medicare beneficiaries, totaling 301,117 services with total Medicare billing of $4.2M. Data is available for 4 years (2020–2023), covering 200 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Chevy Chase, MD
- Active Since 07/20/2005
- Last Updated 06/26/2012
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1104825249
Products in Payments
- Da Vinci Surgical System (Device) $1,116
- SYNVISC-ONE (Device) $540.00
- SIMPONI ARIA (Biological) $171.67
- Letairis (Drug) $103.45
- XELJANZ (Drug) $45.80
- OPSUMIT MACITENTAN (Drug) $39.77
- SIMPONI (Biological) $26.30
- PENNSAID (Drug) $22.36
- Tavneos (Drug) $20.08
- Humira (Biological) $18.85
- BENLYSTA (Biological) $18.28
- Uloric (Drug) $18.21
- Enbrel (Biological) $15.47
- INFLECTRA (Biological) $14.63
- PREVNAR - 13 (Biological) $10.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.